This Week in Cardiology cover image

Jun 23 2023 This Week in Cardiology

This Week in Cardiology

00:00

LODO's Culture Scene: A Positive Trial

The drug looks to have a consistent effect. It's a modest reducer of non-fatal cardiac events. Most positive thing I can say is that it works in addition to really good background therapy and the rates of gout were substantially lower in LODO2. And scientifically this piques your interest right because it's the first anti-inflammatory drug to market for cardiovascular disease.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app